Impact of Short-Term Glucocorticoid Therapy on Regulatory T Cells
Author Information
Author(s): Sbiera Silviu, Dexneit Thomas, Reichardt Sybille D., Michel Kai D., van den Brandt Jens, Schmull Sebastian, Kraus Luitgard, Beyer Melanie, Mlynski Robert, Wortmann Sebastian, Allolio Bruno, Reichardt Holger M., Fassnacht Martin
Primary Institution: University Hospital, University of Würzburg, Germany
Hypothesis
Does short-term glucocorticoid therapy influence the frequency of regulatory T cells in humans and mice?
Conclusion
Short-term glucocorticoid therapy does not increase the frequency of circulating regulatory T cells in either humans or mice.
Supporting Evidence
- Glucocorticoid treatment in mice decreased Treg cell numbers in blood and spleen.
- Human subjects showed increased leukocyte counts but no significant change in Treg cell frequency.
- Different markers for Treg cells yielded varying results in their characterization.
Takeaway
This study found that giving steroids for a short time does not increase the number of special immune cells that help keep our body from attacking itself.
Methodology
Mice were treated with dexamethasone and patients received prednisolone, with Treg cells analyzed before and after treatment.
Potential Biases
Potential bias due to the arbitrary choice of glucocorticoid dosage and the specific patient population studied.
Limitations
The study only analyzed selected time points and used various markers for Treg cell characterization.
Participant Demographics
16 patients with sudden hearing loss, 10 males and 6 females, mean age 35.8 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website